entertainment -WSS

entertainment

author：comprehensive 2025-08-12 08:25:47 - browse：677

Alnylam headquarters — Kristoffer Tripplaar/Sipa USA/AP

A group of advisers to the Food and Drug Administration voted in favor of Alnylam Pharmaceuticals’ treatment for a debilitating heart disease Wednesday, but only after a day-long debate challenging whether the drug’s modest observed effects were actually meaningful for patients.

The group of independent experts voted 9-3 that the benefits of Alnylam’s drug, called patisiran, outweighed its risks for patients with ATTR-CM, a progressive disease that leads to fatal heart failure if left untreated. The FDA, which is not required to follow the advice of advisers, is expected to make a final decision on patisiran by Oct. 8.

“It’s like a light wind blowing in favor of patisiran over placebo,” said David Cella, a neurologist at the Northwestern University Feinberg School of Medicine who voted in favor of patisiran. David Moliterno, a cardiologist at the University of Kentucky, added that “the good news in this story is that while there may be a small benefit, it doesn’t look like there’s a signal for harm.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Cherokee Nation medical school graduates its first class

WSS

It was time to plan for my old age. If only I could stop crying

Lilly’s weekly insulin works as well as daily products, new studies show

Restaurant meals are packed with calories, and we still keep eating them

A fugitive mob suspect in Greece is betrayed by his passion for hometown Naples soccer champions

Pennsylvania man bitten on the head by bear during attack in his garage

Sweden knocks USA out of World Cup in penalty kicks

hotspot

entertainment

entertainment

Drug repurposing or repositioning? The language matters

What a koala virus tells us about the human genome

At least 13 dead in Texas as scorching temps continue

STAT series 'Denied by AI' wins major journalism prizes

Moonlake's readout produced a cash windfall. Risks remain

The United States must get value

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The White House hikes tariffs on plastic syringes made in China

Medical records are filled with copy

Judge in Trump's classified documents case questions use of out

Wikipedia

Election results set back Medicaid expansion plans

Obesity drug from Roche shows promise in early study

Many breast cancer patients receive more radiation than needed

CVS is willing to dump 10% of its Medicare Advantage members

Novo Nordisk testing Wegovy against alcohol

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

Wikipedia

explore

explore

hotspot